Home » Topics » BioWorld Science

BioWorld Science
RSS

FA-70D: a new cathepsin inhibitor from Taiho

Dec. 17, 1997

New dihydropyridine derivatives with cardiovascular activity from Mercian

Dec. 17, 1997

Sumitomo synthesizes new series of ECE inhibitors

Dec. 17, 1997

Dainippon discloses new H+/K+-ATPase inhibitors

Dec. 17, 1997

Neovascularization inhibitors from Tsumura Juntendo

Dec. 17, 1997

Farnesyltransferase inhibitors claimed by Banyu

Dec. 17, 1997

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Glaucoma diagnostic technology covered by U.S. patent

Dec. 17, 1997

Astra Merck and P&G to develop OTC formulation of Prilosec for heartburn

Dec. 17, 1997

Company Profile: Cubist Pharmaceuticals

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...